Table 1 Correlation between SNHG16 expression and clinicopathological features in OS patients
From: LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p
Variables | SNHG16 expression levels | P | |
|---|---|---|---|
Low | High | ||
Sex | |||
 Male | 17 | 12 | 0.152 |
Female | 8 | 13 | |
Age | |||
  ≤ 20 | 10 | 13 | 0.395 |
  > 20 | 15 | 12 | |
Location | |||
 Femur/Tibia | 21 | 19 | 0.480 |
 Elsewhere | 4 | 6 | |
Tumor size (cm) | |||
  ≤ 5 | 8 | 12 | 0.248 |
  > 5 | 17 | 13 | |
Clinical stage | |||
 I + IIA | 12 | 5 | 0.037 |
 IIB/III | 13 | 20 | |
Distant Metastasis | |||
 Yes | 7 | 9 | 0.544 |
 No | 18 | 16 | |